Reckitt Benckiser Group (OTCMKTS:RBGLY – Get Free Report) was upgraded by stock analysts at HSBC from a “hold” rating to a “buy” rating in a report released on Wednesday,Briefing.com Automated Import reports.
Several other equities analysts have also commented on the stock. Sanford C. Bernstein lowered shares of Reckitt Benckiser Group from a “strong-buy” rating to a “hold” rating in a report on Monday, November 4th. Barclays raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Friday, October 4th. Citigroup raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a report on Tuesday, October 1st. UBS Group raised shares of Reckitt Benckiser Group to a “strong-buy” rating in a research note on Wednesday, September 18th. Finally, JPMorgan Chase & Co. cut Reckitt Benckiser Group from an “overweight” rating to a “neutral” rating in a research note on Thursday, August 29th. One analyst has rated the stock with a sell rating, three have assigned a hold rating, one has issued a buy rating and three have assigned a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy”.
View Our Latest Report on RBGLY
Reckitt Benckiser Group Price Performance
Reckitt Benckiser Group Company Profile
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Featured Stories
- Five stocks we like better than Reckitt Benckiser Group
- What is the Australian Securities Exchange (ASX)
- The Great CPU Race: AMD and Intel Battle for Dominance
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- GameStop Turns a Profit: So What? It’s Still Not Worth Investing
- What Are Earnings Reports?
- C3.ai Stock Surges on Strong Sales Despite Profit Concerns
Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.